Solna, Sweden, November 7, 2025 - Vivesto AB, an oncology-focused development company, today announced positive interim results obtained in Vivesto's open label, clinical pilot study with Paccal Vet i ...
The latest update is out from Vivesto AB ( (SE:VIVE) ).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback